Skip to main content

Table 2 Cox-regression analysis: hazard ratios for discontinuation of golimumab

From: Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases

 

Hazard ratio

95% Confidence interval

P

Gender (women vs men)

1.47

1.15–1.87

0.002

Axial SpA vs RA

0.61

0.46–0.81

0.001

PsA versus RA

0.58

0.43–0.77

< 0.001

Third versus second biological drug

1.09

0.84–1.42

0.507

Fourth or further versus second biological drug

1.35

1.02–1.78

0.034

Back to article page

Advances in Rheumatology

ISSN: 2523-3106